190 related articles for article (PubMed ID: 23441855)
1. Erbium: YAG laser ablation versus 70% trichloroacetıc acid application in the treatment of xanthelasma palpebrarum.
Güngör S; Canat D; Gökdemir G
J Dermatolog Treat; 2014 Aug; 25(4):290-3. PubMed ID: 23441855
[TBL] [Abstract][Full Text] [Related]
2. Management of Diffuse Xanthelasma Palpebrarum Using Trichloroacetic Acid Application to Reduce Lesions Followed by Surgical Excision.
Osaki TH; Osaki MH
Aesthet Surg J; 2019 Jan; 39(1):NP6-NP8. PubMed ID: 30383241
[No Abstract] [Full Text] [Related]
3. Evaluation of three different strengths of trichloroacetic acid in xanthelasma palpebrarum.
Haque MU; Ramesh V
J Dermatolog Treat; 2006; 17(1):48-50. PubMed ID: 16467024
[TBL] [Abstract][Full Text] [Related]
4. Assessment of efficacy and tolerability of different concentrations of trichloroacetic acid vs. carbon dioxide laser in treatment of xanthelasma palpebrarum.
Mourad B; Elgarhy LH; Ellakkawy HA; Elmahdy N
J Cosmet Dermatol; 2015 Sep; 14(3):209-15. PubMed ID: 26251333
[TBL] [Abstract][Full Text] [Related]
5. Erbium:yttrium aluminum garnet laser versus Q-switched neodymium:yttrium aluminum garnet laser for the treatment of xanthelasma palpebrarum.
Balevi A; Ustuner P; Ozdemir M
J Cosmet Laser Ther; 2017 Apr; 19(2):100-105. PubMed ID: 27849400
[TBL] [Abstract][Full Text] [Related]
6. Long-wave plasma radiofrequency ablation for treatment of xanthelasma palpebrarum.
Baroni A
J Cosmet Dermatol; 2019 Feb; 18(1):121-123. PubMed ID: 29493071
[TBL] [Abstract][Full Text] [Related]
7. Koebner phenomenon in xanthelasma after treatment with trichloroacetic acid.
Akhyani M; Daneshpazhooh M; Jafari AK; Naraghi ZS; Farahani F; Toosi S
Dermatol Online J; 2006 Feb; 12(2):12. PubMed ID: 16638405
[TBL] [Abstract][Full Text] [Related]
8. Xanthelasma palpebrarum: treatment with the erbium:YAG laser.
Borelli C; Kaudewitz P
Lasers Surg Med; 2001; 29(3):260-4. PubMed ID: 11573229
[TBL] [Abstract][Full Text] [Related]
9. A Clinical and Dermatoscopic Perspective of the Efficacy and Safety of Erbium: YAG Laser Ablation Versus 50% Trichloroacetic Acid for the Management of Xanthelasma Palpebrarum.
Arora A; Mohta A; Mehta RD; Ghiya BC; Soni P; Jangir VK; Yadav MK; Khokhar R; Mangava V
J Cutan Aesthet Surg; 2024; 17(1):1-6. PubMed ID: 38736854
[TBL] [Abstract][Full Text] [Related]
10. Treatment of xanthelasma palpebrarum with a 1064-nm, Q-switched Nd:YAG laser.
Heng JK; Chua SH; Goh CL; Cheng S; Tan V; Tan WP
J Am Acad Dermatol; 2017 Oct; 77(4):728-734. PubMed ID: 28666611
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of trichloroacetic acid (95%) in the management of xanthelasma palpebrarum.
Cannon PS; Ajit R; Leatherbarrow B
Clin Exp Dermatol; 2010 Dec; 35(8):845-8. PubMed ID: 20456397
[TBL] [Abstract][Full Text] [Related]
12. New operative technique for treatment of xanthelasma palpebrarum: laser-inverted resurfacing: preliminary report.
Levy JL; Trelles MA
Ann Plast Surg; 2003 Apr; 50(4):339-43. PubMed ID: 12671372
[TBL] [Abstract][Full Text] [Related]
13. [Treatment of peri-ocular skin lesions with the erbium:YAG laser].
Riedel F; Windberger J; Stein E; Hörmann K
Ophthalmologe; 1998 Nov; 95(11):771-5. PubMed ID: 9857638
[TBL] [Abstract][Full Text] [Related]
14. Treatment of eyelid xanthelasma with 70% trichloroacetic acid.
Nahas TR; Marques JC; Nicoletti A; Cunha M; Nishiwaki-Dantas MC; Filho JV
Ophthalmic Plast Reconstr Surg; 2009; 25(4):280-3. PubMed ID: 19617785
[TBL] [Abstract][Full Text] [Related]
15. Fractional CO
Al-Kady NA; Hamdino M; Abdel Kawy FAW
J Cosmet Dermatol; 2021 Mar; 20(3):763-768. PubMed ID: 32892481
[TBL] [Abstract][Full Text] [Related]
16. Argon laser versus erbium:YAG laser in the treatment of xanthelasma palpebrarum.
Abdelkader M; Alashry SE
Saudi J Ophthalmol; 2015; 29(2):116-20. PubMed ID: 25892929
[TBL] [Abstract][Full Text] [Related]
17. A prospective study comparing ultrapulse CO2 laser and trichloroacetic acid in treatment of Xanthelasma palpebrarum.
Goel K; Sardana K; Garg VK
J Cosmet Dermatol; 2015 Jun; 14(2):130-9. PubMed ID: 25817385
[TBL] [Abstract][Full Text] [Related]
18. Treatment of xanthelasma palpebrarum by 1064-nm Q-switched Nd:YAG laser: a study of 11 cases.
Fusade T
Br J Dermatol; 2008 Jan; 158(1):84-7. PubMed ID: 17916214
[TBL] [Abstract][Full Text] [Related]
19. Clinical efficacy of 1,444nm Nd:YAG laser for xanthelasma palpebrarum.
Park JH; Ryu SI; Kim IH
J Cosmet Laser Ther; 2020 Apr; 22(3):141-145. PubMed ID: 32436411
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of laser therapy in xanthelasma palpebrarum.
Nguyen AH; Vaudreuil AM; Huerter CJ
Int J Dermatol; 2017 Mar; 56(3):e47-e55. PubMed ID: 28181222
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
